Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-028784·LENZ Therapeutics, Inc.
Schedule 13G ownership disclosure
LENZ THERAPEUTICS INC
Common Stock, $0.00001 par value per share · CUSIP: 52635N103
Event date: 2025-03-20
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Paradigm BioCapital Advisors LP
Shares: 1,419,832.00 · Class: 5.2%
- Paradigm BioCapital Advisors GP LLC
Shares: 1,419,832.00 · Class: 5.2%
- Senai Asefaw, M.D.
Shares: 1,419,832.00 · Class: 5.2%
- Paradigm BioCapital International Fund Ltd.
Shares: 1,254,521.00 · Class: 4.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-028784
- Form type
- SCHEDULE 13G
- Filer
- LENZ Therapeutics, Inc.
- CIK
- CIK 1815776
- Filed
- Mar 27, 2025
- Reporting period
- Mar 20, 2025
- Description
- Schedule 13G beneficial ownership